News

Findings from a placebo-controlled, dose-ranging study of Remicade 3mg/kg and 5mg/kg, showed that every eight-week maintenance therapy resulted in greater long-term skin clearance compared with ‘as-needed’ therapy regimens

The study was a phase IV, multicenter, open-label, randomized study evaluating the long-term efficacy of a lower dosage of Soriatane in 77 psoriasis patients. Patients were randomized to

These studies demonstrated that AN0128 was well tolerated at the site of application and indicated that further study was warranted. “While atopic dermatitis is fundamentally a disease of

The new data was presented at the American Academy of Dermatology (AAD) annual meeting. This is the first study of its kind to show the benefit of administering

The study, which is based on a special protocol assessment issued by the FDA, is evaluating the safety and efficacy of Fampridine-SR in improving walking ability in people

The company is seeking approval to market Revlimid in combination with dexamethasone in a proposed indication for the treatment of multiple myeloma patients who have received at least

The compounds are analogs of Novartis’ Ritalin, used for treatment of ADHD and designed specifically to take effect slowly but last longer, thus reducing their potential for abuse

Nastech’s stock fell by 37% following the end of its partnership with Merck. The companies had been collaborating on the development of nasal spray, PYY3-36 (PYY), for the

Designed to inhibit the function of the epidermal growth factor receptor (EGFR) – a molecular structure linked to tumor growth – Erbitux is the first and only monoclonal